|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Effects of a low-estrogen, desogestrel-containing oral contraceptive on |
| lipid and carbohydrate metabolism. |
| Godsland IF; Crook D; Worthington M; Proudler AJ; Felton C; Sidhu M; |
| CONTRACEPTION. 1993 Sep;48(3):217-27. |
| Fasting serum lipids, lipoproteins and apolipoproteins, and fasting plasma glucose, insulin and C-peptide were |
| measured in 107 nonusers and 83 users of an oral contraceptive (OC) containing the progestin desogestrel, |
| combined with 20 mcg ethinyl estradiol. Plasma glucose, insulin, and C-peptide concentrations during an oral |
| glucose tolerance test (OGTT) were measured in a subgroup of 69 nonusers and 39 users.. Compared with |
| nonusers, users had higher concentrations of total, high density lipoprotein (HDL), HDL subfraction 3 and very low |
| density lipoprotein (VLDL) cholesterol, total triglycerides, VLDL triglycerides, apolipoproteins AI and AII, and fasting |
| plasma insulin. There were no differences in HDL subfraction 2, LDL cholesterol, and apolipoprotein B. OGTT |
| glucose was 60% higher in the users and OGTT insulin response 19% higher. The OGTT C-peptide response did |
| not differ. The effects of 20 mcg ethinyl estradiol combined with 150 mcg desogestrel on lipid, lipoprotein, glucose, |
| and insulin metabolism are similar to those described previously with a 30 mcg ethinyl estradiol combination |
| containing the same dose of desogestrel. The relatively favorable metabolic profile associated with the higher |
| estrogen desogestrel combination is maintained at the lower dose. (PubHealth.info Document ID: CONT2T 4546-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Effects of a low-estrogen, desogestrel-containing oral |
| contraceptive on lipid and carbohydrate metabolism.", is(are) Godsland IF; Crook D; Worthington M; Proudler AJ; |
| Felton C; Sidhu M; Stevenson JC. The source of this article is "CONTRACEPTION. 1993 Sep;48(3):217-27.". This |
| article was published in 1993 in English language(s). (PubHealth.info® Document ID: CONT2T 4546-06. All rights |
| reserved with PubHealth.info) PIN: 9546 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |